Structure Therapeutics (GPCR) said Wednesday it has priced its upsized public offering of about 8.5 million American depositary shares at $65 per ADS.
The company also priced pre-funded warrants to purchase 1.5 million ADSs at $64.9999 per warrant.
One ADS represents three ordinary shares, the company said.
Gross proceeds from the offering, expected to close Thursday, are estimated to be about $650 million.
Underwriters have been granted a 30-day option to purchase up to an additional 1.5 million ADSs.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments